Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Clinical Trial

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Multicenter Study

Publication Year

From

Quick links

Individual year

2024

2008

2007

2004

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Imidazoline Receptors""[mesh_terms]

7 Results

Searching titles within these results

Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.

Andrew Sindone, Maria Marketou, Marcio G Kiuchi, John Parissis, Stefano Taddei, Claudio Ferri, Mark Cooper, Markus P Schlaich, Konstantinos Tsioufis, Claudio Borghi, Ana Maria Vintila, Anca Farcas, Shukrath Chandrappa

Journal of hypertension 2024;42(12):2025-2040

Free Full Text

Abstract

Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.

Peera Buranakitjaroen, Peerapong Kittipawong, Banhan Koanantakul, Chumpol Piamsomboon, Nattanun Prasassarakich, Songkwan Silaraks, Apichard Sukonthasarn, Assada Tiyapant

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2004;86(10):903-10

Full Text

Abstract

I1 receptors, cardiovascular function, and metabolism.

P Bousquet

American journal of hypertension 2002;14(11 Pt 2):317S-321S

Full Text

Abstract

Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.

Matthias Weck

Clinical research in cardiology : official journal of the German Cardiac Society 2008;96(10):707-18

Full Text

Abstract

Drugs for the perioperative control of hypertension: current issues and future directions.

Robert Feneck

Drugs 2008;67(14):2023-44

Full Text

Abstract

Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy.

J E Piletz, U Halbreich

Biological psychiatry 2000;48(9):932-9

Full Text

Abstract

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Giuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, Elena Fogari, Sibilla Salvadeo, Alessia Gravina, Ilaria Ferrari, Raffaella Fassi, Roberto Fogari

Clinical therapeutics 2007;29(4):602-10

Full Text

Abstract

Results: 1 – 7 / 7

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Imidazoline Receptors""[mesh_terms]

Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.

Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.

I1 receptors, cardiovascular function, and metabolism.

Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.

Drugs for the perioperative control of hypertension: current issues and future directions.

Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.

Results for
""Imidazoline Receptors""[mesh_terms]